PMID: 6106915Jan 1, 1980Paper

Changes in body temperature after administration of acetylcholine, histamine, morphine, prostaglandins and related agents

Neuroscience and Biobehavioral Reviews
W G Clark, Y L Clark

Abstract

This survey, the second in a series, presents extensive tabulations of literature, primarily since 1965, on thermoregulatory effects of cholinergic agonists and antagonists, histamine and H1- and H2-receptor antagonists, narcotic analgesics and antagonists in both non-tolerant and tolerant subjects and of prostaglandins and related agents. The information listed includes the species used, route of administration and dose of drug, the environmental temperature at which the experiments were performed, the number of tests, the direction and magnitude of body temperature change and remarks on the presence of special conditions, such as age or lesions, or on the influence of other drugs, such as antagonists, on the response to the primary drug.

References

Jan 15, 1977·Biochemical Pharmacology·D Lewis, L Isaac
Mar 1, 1977·The Journal of Pharmacy and Pharmacology·O H Osman, I B Eltayeb
Apr 7, 1977·European Journal of Pharmacology·T Oka, K Negishi
Apr 1, 1977·Canadian Journal of Physiology and Pharmacology·J G Sinclair, G F Lo
Mar 1, 1978·Pharmacological Research Communications·H F Simon
Mar 19, 1979·Life Sciences·T F Burks, G C Rosenfeld
Jul 29, 1978·Lancet·G NisticòF Naccari
Mar 14, 1979·Psychopharmacology·R Eikelboom, J Stewart
Dec 1, 1975·British Journal of Pharmacology·I B Eltayeb, O H Osman
Apr 6, 1976·Pflügers Archiv : European journal of physiology·W K Philipp-Dormston
Oct 1, 1976·European Journal of Pharmacology·M AryP Lomax
Dec 28, 1976·Pflügers Archiv : European journal of physiology·G H WilliesC Rosendorff
Apr 1, 1979·Pharmacology, Biochemistry, and Behavior·W G Clark
May 1, 1979·Brain Research Bulletin·J M LiptonC B Ticknor
Oct 1, 1979·Pflügers Archiv : European journal of physiology·M T LinC Y Su
Apr 1, 1975·The Journal of Pharmacy and Pharmacology·B Cox, S J Tha
Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J W HoladayC H Li
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J W HoladayC H Li
Oct 1, 1977·Acta Physiologica Scandinavica·K MyhreG Myhre
Feb 1, 1978·British Journal of Pharmacology·W G Clark, J A Robins
Jan 1, 1979·Canadian Journal of Physiology and Pharmacology·L K VaughnK E Cooper
Apr 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·W G Clark, J M Lipton

❮ Previous
Next ❯

Citations

Aug 5, 1983·European Journal of Pharmacology·C AngelW G Reese
Jun 19, 1985·European Journal of Pharmacology·I UshijimaN Nagasaki
Aug 11, 1987·European Journal of Pharmacology·M W Adler, E B Geller
Oct 23, 1990·European Journal of Pharmacology·J Del Rio-Garcia, A Cremades
Jan 1, 1992·Life Sciences·G Volterra, A Lecci
Jun 1, 1985·Physiology & Behavior·A V FergusonW L Veale
Aug 1, 1983·Pharmacology, Biochemistry, and Behavior·N R ShapiroR A Rosellini
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·R Marks-KaufmanE Gross
Aug 1, 1986·Pharmacology, Biochemistry, and Behavior·O E Olorundare, T A Rudy
Aug 1, 1986·Pharmacology, Biochemistry, and Behavior·O E Olorundare, T A Rudy
Jul 1, 1986·Pharmacology, Biochemistry, and Behavior·E S SperberR J Bodnar
Sep 1, 1987·Pharmacology, Biochemistry, and Behavior·R N Pechnick, M J Morgan
Oct 1, 1989·Pharmacology, Biochemistry, and Behavior·J K Belknap
Mar 1, 1993·Pharmacology, Biochemistry, and Behavior·L H Raible, D Knickerbocker
Jan 1, 1982·Pharmacology & Therapeutics·R Hellon, Y Townsend
Jan 1, 1983·Pharmacology & Therapeutics·W G Clark, J M Lipton
Jan 1, 1984·Pharmacology & Therapeutics·W G Clark, J M Lipton
Aug 1, 1983·Journal of the Autonomic Nervous System·R ShuklaB N Dhawan
Nov 1, 1985·Peptides·M S AhmedC M Blatteis
Jul 1, 1986·Prostaglandins, Leukotrienes, and Medicine·H M Gollman, T A Rudy
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·S C Dilsaver, N E Alessi
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·R P MaickelM B Nichols
Sep 1, 1981·Brain Research Bulletin·W G ClarkS W Ponder
Mar 1, 1983·Brain Research Bulletin·S M ClarkW G Clark
Apr 1, 1985·Brain Research Bulletin·M Holdeman, J M Lipton
Jan 1, 1986·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·V H Hutchison, K K Spriestersbach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.